Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 55.00
-2.50 (-4.35%)
Feb 12, 2026, 4:35 PM GMT
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of 66.58 million as of February 12, 2026. Its market cap has decreased by -63.64% in one year.
Market Cap
66.58M
Enterprise Value
74.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
55.00
Market Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 53.46M to 66.58M, an increase of 24.53%. That is a compound annual growth rate of 2.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 66.58M | -67.67% |
| Dec 31, 2025 | 205.96M | -3.97% |
| Dec 31, 2024 | 214.48M | 2.23% |
| Dec 29, 2023 | 209.80M | 16.93% |
| Dec 30, 2022 | 179.42M | 26.00% |
| Dec 31, 2021 | 142.40M | 16.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 128.68M |
| Bioventix | 92.74M |
| 4basebio | 91.32M |
| hVIVO | 60.21M |
| Hemogenyx Pharmaceuticals | 57.75M |
| SkinBioTherapeutics | 51.13M |
| Ondine Biomedical | 41.09M |
| Poolbeg Pharma | 32.43M |